Conditions such as rheumatoid arthritis, lupus, multiple sclerosis, and Hashimoto's thyroiditis are linked to oxidative stress and immune system imbalances[4]
Its being studied for more (addiction, mental health, Alzheimers) Prices are coming down (Zepbound is 20% less expensive than Wegovy) But, on the other hand: Medicare is legally prevented from covering GLP1s for obesity Only 16 states cover anti-obesity medications under Medicaid 50% or less commercial plans cover GLP1s for obesity, and those that do often have unreasonable hurdles Covered can still mean $500-1000 out of pocket every month
According to the current studys findings, ROSE-010 is linked to a greater incidence of headaches, nausea, and vomiting than placebo
NICE guidance suggests that a 510% reduction in initial body weight produces clinically meaningful improvements in cardiovascular risk factors, glycaemic control, and quality of life